Document Detail


Therapeutic effects of microRNA-582-5p and -3p on the inhibition of bladder cancer progression.
MedLine Citation:
PMID:  23295946     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Many reports have indicated that the abnormal expression of microRNAs (miRNAs) is associated with the progression of disease and have identified miRNAs as attractive targets for therapeutic intervention. However, the bifunctional mechanisms of miRNA guide and passenger strands in RNA interference (RNAi) therapy have not yet been clarified. Here, we show that miRNA (miR)-582-5p and -3p, which are strongly decreased in high-grade bladder cancer clinical samples, regulate tumor progression in vitro and in vivo. Significantly, the overexpression of miR-582-5p or -3p reduced the proliferation and invasion of UM-UC-3 human bladder cancer cells. Furthermore, transurethral injections of synthetic miR-582 molecule suppressed tumor growth and metastasis in an animal model of bladder cancer. Most interestingly, our study revealed that both strands of miR-582-5p and -3p suppressed the expression of the same set of target genes such as protein geranylgeranyltransferase type I beta subunit (PGGT1B), leucine-rich repeat kinase 2 (LRRK2) and DIX domain containing 1 (DIXDC1). Knockdown of these genes using small interfering RNA (siRNA) resulted in the inhibition of cell growth and invasiveness of UM-UC-3. These findings uncover the unique regulatory pathway involving tumor suppression by both strands of a single miRNA that is a potential therapeutic target in the treatment of invasive bladder cancer.
Authors:
Keita Uchino; Fumitaka Takeshita; Ryou-U Takahashi; Nobuyoshi Kosaka; Kae Fujiwara; Haruna Naruoka; Satoru Sonoke; Junichi Yano; Hideo Sasaki; Shiari Nozawa; Miki Yoshiike; Kazuki Kitajima; Tatsuya Chikaraishi; Takahiro Ochiya
Related Documents :
24386506 - Nicotinamide phosphoribosyltransferase in malignancy: a review.
23308046 - Fluorine-labeled dasatinib nanoformulations as targeted molecular imaging probes in a p...
11059766 - Treatment of colorectal liver metastases by adenoviral transfer of tissue inhibitor of ...
11448356 - Expression of matrix metalloproteinases and their inhibitors correlates with invasion a...
25405986 - Myofibroblast-derived sfrp1 as potential inhibitor of colorectal carcinoma field effect.
22633196 - Clinical significance of endoscopic ultrasound for gastric submucosal tumors.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2013-01-08
Journal Detail:
Title:  Molecular therapy : the journal of the American Society of Gene Therapy     Volume:  21     ISSN:  1525-0024     ISO Abbreviation:  Mol. Ther.     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-03-01     Completed Date:  2013-10-22     Revised Date:  2014-03-07    
Medline Journal Info:
Nlm Unique ID:  100890581     Medline TA:  Mol Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  610-9     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Alkyl and Aryl Transferases / genetics,  metabolism
Animals
Cell Line, Tumor
Cell Proliferation
Disease Models, Animal
Disease Progression
Down-Regulation
Female
Gene Expression Regulation, Neoplastic*
Genetic Therapy
Humans
Intracellular Signaling Peptides and Proteins / genetics,  metabolism
Mice
Mice, Inbred BALB C
Mice, Nude
MicroRNAs / genetics,  therapeutic use*
Microfilament Proteins / genetics,  metabolism
Protein-Serine-Threonine Kinases / genetics,  metabolism
RNA Interference
RNA, Small Interfering / genetics
Urinary Bladder Neoplasms / genetics*,  pathology,  therapy*
Chemical
Reg. No./Substance:
0/DIXDC1 protein, human; 0/Intracellular Signaling Peptides and Proteins; 0/MicroRNAs; 0/Microfilament Proteins; 0/RNA, Small Interfering; EC 2.5.-/Alkyl and Aryl Transferases; EC 2.5.1.-/geranylgeranyltransferase type-I; EC 2.7.11.1/LRRK2 protein, human; EC 2.7.11.1/Protein-Serine-Threonine Kinases
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Bispecific T-cells expressing polyclonal repertoire of endogenous ?? T-cell receptors and introduced...
Next Document:  HDAC inhibition suppresses primary immune responses, enhances secondary immune responses, and abroga...